Wings for Life

Developer of neurological disorders therapy designed for critical mediators of inhibition within the brain. The company's platform has developed a proprietary neuron-specific K-Cl cotransporter (KCC2) discovery engine to improve the lives of people suffering from neurological disorders by fine-tuning inhibition to treat conditions such as epilepsy, pain, and other central nervous system pathologies, thereby enabling the healthcare industry to resist neurodegeneration, restore excitation, and regenerate neurons.

ReNetX Bio, Inc., a biotechnology company, develops and markets therapeutics to treat injury/damage to the central nervous system. It offers Nogo Trap, a decoy receptor that binds the growth inhibitors allowing the body to grow nerve fibers naturally and directly targeting restoration across all facets of growth, such as axonal regeneration, axonal sprouting, and synaptic plasticity. The company offers treatment for central nervous system for conditions, such as spinal cord injury, stroke, and glaucoma. ReNetX Bio, Inc. was formerly known as Axerion Therapeutics, Inc. and changed its name to ReNetX Bio, Inc. in July 2017. The company was incorporated in 2009 and is based in New Haven, Connecticut.